Literature DB >> 21593630

Papilledema: the vexing issues.

Jonathan D Trobe1.   

Abstract

Papilledema has long been recognized as a valuable sign of increased intracranial pressure (ICP). But because papilledema is based on interruption of the energy-dependent process of axoplasmic flow, it appears late after a rise in ICP. Papilledema is usually present in chronically high ICP but sometimes asymmetrically in the 2 eyes and rarely in 1 eye only. Distinguishing it from other optic neuropathies that produce elevated optic discs is challenging, especially in the chronic phase, when visual function may be impaired. Papilledema is often an unrecognized cause of optic disc edema in inflammatory and compressive meningeal disorders that interfere with cerebrospinal fluid (CSF) passage through the arachnoid granulations. Its detection is particularly critical in patients with noncompliant ventricles or extraventricular blockage of cerebrospinal flow because imaging may fail to disclose conventional signs of high ICP. Therefore, patients with indwelling CSF shunts, tuberous sclerosis, chronic granulomatous meningitis, or meningiomatosis should be periodically examined for papilledema so that timely ICP-lowering measures can be instituted to preserve vision.

Entities:  

Mesh:

Year:  2011        PMID: 21593630     DOI: 10.1097/WNO.0b013e31821a8b0b

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  20 in total

1.  Automated quantitation of the posterior scleral flattening and optic nerve protrusion by MRI in idiopathic intracranial hypertension.

Authors:  N Alperin; A M Bagci; B L Lam; E Sklar
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

2.  The Photopic Negative Response in Idiopathic Intracranial Hypertension.

Authors:  Heather E Moss; Jason C Park; J Jason McAnany
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

3.  The Pseudotumor Cerebri Syndrome: A Unifying Pathophysiological Concept for Patients with Isolated Intracranial Hypertension with Neither Mass Lesion Nor Ventriculomegaly.

Authors:  G M Halmagyi; R M Ahmed; I H Johnston
Journal:  Neuroophthalmology       Date:  2014-07-24

Review 4.  MR imaging of papilledema and visual pathways: effects of increased intracranial pressure and pathophysiologic mechanisms.

Authors:  N Passi; A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

5.  Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension.

Authors:  Patrick Sibony; Mark J Kupersmith; Robert Honkanen; F James Rohlf; Ali Torab-Parhiz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

6.  Optical coherence tomography use in idiopathic intracranial hypertension.

Authors:  Kiran Malhotra; Tanyatuth Padungkiatsagul; Heather E Moss
Journal:  Ann Eye Sci       Date:  2020-03-15

7.  Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.

Authors:  Leena V Padhye; Gregory P Van Stavern; Aseem Sharma; Ryan Viets; Julie B Huecker; Mae O Gordon
Journal:  J Neurol Sci       Date:  2013-07-11       Impact factor: 3.181

8.  Fulminant Idiopathic Intracranial Hypertension With Malignant Systemic Hypertension-A Case Report.

Authors:  Hina N Abbasi; Adrian J Brady; Sarah A Cooper
Journal:  Neuroophthalmology       Date:  2013-05-31

9.  Hyperintense optic nerve heads on diffusion-weighted imaging: a potential imaging sign of papilledema.

Authors:  R Viets; M Parsons; G Van Stavern; C Hildebolt; A Sharma
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

Review 10.  Pathogenesis and Evaluation of the Effects of Idiopathic Intracranial Hypertension on the Optic Nerves.

Authors:  Nada Elsaid; Omar Ahmed; Tamer Belal; Ahmed Razek; Ahmed Azab
Journal:  Neuroophthalmology       Date:  2020-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.